Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Neurosecretion”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 253 records · Page 14Linked to original sources
PubMed1998

Prejunctional 5-HT receptors enhance cholinergic neurosecretion in the rabbit and human iris-ciliary body.

PURPOSE: To characterize prejunctional 5-HT heteroreceptors which modulate 3Hacetylcholine (3H-ACh release) in isolated rabbit and human iris-ciliary bodies (ICB3). METHODS: ICB tissue segments were incubated with 3H-choline, superfused and electrically stimulated four times (S1, S2, S3, S4) at 3-10 Hz for 1 min to elicit 3H-ACh. secretion. Test agents (5-HT agonists and antagonists) were added before S2, S3 and S4 and their effects determined by the stimulation ratio (Sx/S1) of evoked 3H-ACh. release. 3H-ACh in superfusate fractions was fractionated and quantified by ion exchange chromatography. RESULTS: In rabbit ICBs, evoked 3H-ACh. release was enhanced in a concentration-dependent manner by 5-HT (10(-9)-10(-5) M, EC50 = 5.8 x 10(-8) M). The maximum effect of 5-HT (10(-6) M) corresponded to a 45.14 +/- 7.40%) (n = 6) increase in 3H-ACh release. Higher concentrations of 5-HT (> 10(-4) M) induced desensitization. The response to 5-HT (10(-6) M) in the presence of the 5-HT3/4 antagonist tropisetron (10(-9) M), 5-HT1 antagonist methiothepin ((10(-7) M), equated to 89.96% and 88.78% respectively of control value; in the presence of non-selective 5-HT antagonist mianserin, 5-HT4 antagonist SDZ-205557 (10(-7) M) was -15.20% and 32.84% of control. The 5-HT response was mimicked by the selective 5-HT4 agonist 5-methoxytryptamine (10(-9)-10(-4) M, EC50 = 7 x 10(-8) M), whereas the 5-HT3 agonist M-CPBG[(1-m-chlorophenyl)-biguanide] and phenylbiguanide, the 5-HT1 agonist 5-carboxamidotryptamine and the 5-HT2A agonist alpha-methyl-5-HT were ineffective. The selective 5-HT1A agonist (+)-8-OH-DPAT (10(-8)-10(-5) M) had no significant effect, but at concentration of 10(-4) M, inhibited evoked 3H-Ach. release. Similar results were obtained in the human ICB. The evoked 3H-Ach. release was enhanced in a concentration-dependent manner by 5-HT (10(-9)-10(-5) M, EC50 = 3.36 x 10(-8) M) or 5-MOT (10(-8)-10(-5) M, EC50 = 6.59 x 10(-7) M), The selective 5-HT4 antagonist, GR113808A (10(-8) M) inhibited the 5-HT-inducing increase of the cholinergic response, producing parallel right shits of the concentration-response curves to 5-HT. The selective 5-HT3 antagonist ondersetrone (5 x 10(-7) M) and tropisetron (10(-9) M) did not affect 5-HT inducing 3H-Ach release. CONCLUSIONS: Our results indicate that cholinergic terminals in the rabbit and human ICB contain facilitatory 5-HT heteroreceptors that belong to the 5-HT4 subtype. Their role in modulation of intraocular pressure remains to be elucidated.

Acetylcholine↗